BIOMAT Database Logo BIOMAT Database Logo

Tumorigenicity and immunogenicity in a murine model of B-cell leukemia/lymphoma (BCL1). 1998

S Morecki, and A Nagler, and Z Zakay-Rones, and M Schlesinger, and A Lubina-Salomon, and T Pugatsch, and Y Moshel, and S Slavin
The Department of Bone Marrow Transplantation, Hadassah University Hospital, Jerusalem, Israel.

Multiple injections of intact irradiated BCL1 cells, a murine B-cell leukemia/lymphoma can trigger a dose-dependent anti-tumor immune response in naive syngeneic mice. The ability to induce anti-BCL1 immunity and the effect of various cell-modifications on BCL1 tumorigenicity and immunogenicity was evaluated. Newcastle disease virus (NDV) infection or transfer of cytokine genes by both retroviral and Adeno 5 vectors affect neither tumorigenicity nor immunogenicity of BCL1 cells given as a non-immunogenic cell-dose. New ways will have to be developed to elicit a reliable and reproducible anti-tumor effect in spontaneously arising and non-immunogenic hematological malignancies.

UI MeSH Term Description Entries
D007114 Immunization Deliberate stimulation of the host's immune response. ACTIVE IMMUNIZATION involves administration of ANTIGENS or IMMUNOLOGIC ADJUVANTS. PASSIVE IMMUNIZATION involves administration of IMMUNE SERA or LYMPHOCYTES or their extracts (e.g., transfer factor, immune RNA) or transplantation of immunocompetent cell producing tissue (thymus or bone marrow). Immunologic Stimulation,Immunostimulation,Sensitization, Immunologic,Variolation,Immunologic Sensitization,Immunological Stimulation,Sensitization, Immunological,Stimulation, Immunologic,Immunizations,Immunological Sensitization,Immunological Sensitizations,Immunological Stimulations,Sensitizations, Immunological,Stimulation, Immunological,Stimulations, Immunological,Variolations
D007371 Interferon-gamma The major interferon produced by mitogenically or antigenically stimulated LYMPHOCYTES. It is structurally different from TYPE I INTERFERON and its major activity is immunoregulation. It has been implicated in the expression of CLASS II HISTOCOMPATIBILITY ANTIGENS in cells that do not normally produce them, leading to AUTOIMMUNE DISEASES. Interferon Type II,Interferon, Immune,gamma-Interferon,Interferon, gamma,Type II Interferon,Immune Interferon,Interferon, Type II
D007376 Interleukin-2 A soluble substance elaborated by antigen- or mitogen-stimulated T-LYMPHOCYTES which induces DNA synthesis in naive lymphocytes. IL-2,Lymphocyte Mitogenic Factor,T-Cell Growth Factor,TCGF,IL2,Interleukin II,Interleukine 2,RU 49637,RU-49637,Ro-23-6019,Ro-236019,T-Cell Stimulating Factor,Thymocyte Stimulating Factor,Interleukin 2,Mitogenic Factor, Lymphocyte,RU49637,Ro 23 6019,Ro 236019,Ro236019,T Cell Growth Factor,T Cell Stimulating Factor
D007942 Leukemia, Experimental Leukemia induced experimentally in animals by exposure to leukemogenic agents, such as VIRUSES; RADIATION; or by TRANSPLANTATION of leukemic tissues. Experimental Leukemia,Experimental Leukemias,Leukemia Model, Animal,Leukemias, Experimental,Animal Leukemia Model,Animal Leukemia Models,Leukemia Models, Animal
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D009368 Neoplasm Transplantation Experimental transplantation of neoplasms in laboratory animals for research purposes. Transplantation, Neoplasm,Neoplasm Transplantations,Transplantations, Neoplasm
D009522 Newcastle disease virus The most well known avian paramyxovirus in the genus AVULAVIRUS and the cause of a highly infectious pneumoencephalitis in fowl. It is also reported to cause CONJUNCTIVITIS in humans. Transmission is by droplet inhalation or ingestion of contaminated water or food. Avian Paramyxovirus 1,Paramyxovirus 1, Avian
D004306 Dose-Response Relationship, Immunologic A specific immune response elicited by a specific dose of an immunologically active substance or cell in an organism, tissue, or cell. Immunologic Dose-Response Relationship,Relationship, Immunologic Dose-Response,Dose Response Relationship, Immunologic,Dose-Response Relationships, Immunologic,Immunologic Dose Response Relationship,Immunologic Dose-Response Relationships,Relationship, Immunologic Dose Response,Relationships, Immunologic Dose-Response
D000256 Adenoviridae A family of non-enveloped viruses infecting mammals (MASTADENOVIRUS) and birds (AVIADENOVIRUS) or both (ATADENOVIRUS). Infections may be asymptomatic or result in a variety of diseases. Adenoviruses,Ichtadenovirus,Adenovirus,Ichtadenoviruses
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

S Morecki, and A Nagler, and Z Zakay-Rones, and M Schlesinger, and A Lubina-Salomon, and T Pugatsch, and Y Moshel, and S Slavin
Tumor-cell vaccination induces tumor dormancy in a murine model of B-cell leukemia/lymphoma (BCL1).
January 1996, International journal of cancer,
S Morecki, and A Nagler, and Z Zakay-Rones, and M Schlesinger, and A Lubina-Salomon, and T Pugatsch, and Y Moshel, and S Slavin
Immunobiology of a spontaneous murine B cell leukemia (BCL1).
January 1979, Immunological reviews,
S Morecki, and A Nagler, and Z Zakay-Rones, and M Schlesinger, and A Lubina-Salomon, and T Pugatsch, and Y Moshel, and S Slavin
Murine B-cell leukemia lymphoma (BCL1) cells as a target for NK cell-mediated immunotherapy.
June 2004, Bone marrow transplantation,
S Morecki, and A Nagler, and Z Zakay-Rones, and M Schlesinger, and A Lubina-Salomon, and T Pugatsch, and Y Moshel, and S Slavin
The pathology and homing of a transplantable murine B cell leukemia (BCL1).
September 1979, Journal of immunology (Baltimore, Md. : 1950),
S Morecki, and A Nagler, and Z Zakay-Rones, and M Schlesinger, and A Lubina-Salomon, and T Pugatsch, and Y Moshel, and S Slavin
Cytogenetic analysis of the spontaneous murine B-cell leukemia (BCL1).
January 1980, Leukemia research,
S Morecki, and A Nagler, and Z Zakay-Rones, and M Schlesinger, and A Lubina-Salomon, and T Pugatsch, and Y Moshel, and S Slavin
A new in vivo and in vitro B cell lymphoma model, pi-BCL1.
December 2000, Cancer biotherapy & radiopharmaceuticals,
S Morecki, and A Nagler, and Z Zakay-Rones, and M Schlesinger, and A Lubina-Salomon, and T Pugatsch, and Y Moshel, and S Slavin
Minimal residual disease in murine B-cell leukemia (BCL1) detected by PCR.
November 1993, Leukemia research,
S Morecki, and A Nagler, and Z Zakay-Rones, and M Schlesinger, and A Lubina-Salomon, and T Pugatsch, and Y Moshel, and S Slavin
Proliferative response of murine B-cell leukemia (BCL1) to poly(L-lysine).
February 1985, Cellular immunology,
S Morecki, and A Nagler, and Z Zakay-Rones, and M Schlesinger, and A Lubina-Salomon, and T Pugatsch, and Y Moshel, and S Slavin
Demonstration and characterization of virus released by murine B cell leukemia cells (BCL1).
January 1984, Leukemia research,
S Morecki, and A Nagler, and Z Zakay-Rones, and M Schlesinger, and A Lubina-Salomon, and T Pugatsch, and Y Moshel, and S Slavin
BCL1, a murine model of prolymphocytic leukemia. II. Morphology and ultrastructure.
December 1981, The American journal of pathology,
Copied contents to your clipboard!